Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
- Caspian Fairholm
- 13 Jan 2026
- Medications
Proving bioequivalence for complex generic drugs-like inhalers, creams, and injectables-is far harder than for simple pills. Without reliable testing methods and standardized regulations, these life-saving generics remain rare and expensive.
View More